Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Hum Pathol. 2009 Dec 11;41(4):540–551. doi: 10.1016/j.humpath.2009.09.007

Table 2.

Immunohistochemistry (% positive)

Number of Patients (BP/MP/UC) Biphasic Monophasic Unclassifiable
CD5 16/14/15 6 7 13
CD23 15/14/16 0 14 13
CD10 15/14/16 0 0 0
CD43 16/14/12 0 21^ 25^^
Bcl-2 16/14/14 100 100 100
Bcl-6 16/14/16 0 7 0
IRF4/MUM1 15/14/16 27 29 31
IgD 15/14/14 93 64# 57*
Cyclin D1 16/14/16 0 0 0
CD5(−), CD10(−), CD43(−), CD23(−) 15/14/13 94 64# 69
IgD(+), CD5(−), CD10(−), CD43(−), CD23(−) 15/14/13 87 29** 23**
*

p < 0.04 vs. BP

**

p < 0.003 vs. BP

#

p = 0.08 vs. BP

^

p = 0.09 vs. BP

^^

p = 0.07 vs BP

BP-biphasic, MP-monophasic, UC-unclassifiable